By Stewart Eisenhart, Emergo Group
The US Food and Drug Administration recently added a new timeline to its 510(k) premarket notification webpage that summarizes typicalcommunications between agency reviewers and medical device applicants between submission and final clearance.
The FDA published its new chart to meet 510(k) performance goals set up by the Medical Device User Fee Amendments of 2012 (MDUFA III). The chart indicates a 90-day timeframe for most 510(k) clearance decisions, and spells out what manufacturers can expect in terms of possible communications with FDA reviewers during their US medical device registration process.
Generally, 510(k) applicants can expect submission acceptance review decisions within 15 calendar days; substantive review decisions within 60 days; and final decisions within 90 days. Applicants with outstanding review issues will be notified within 100 days.
Prior to MDUFA III, medical device industry advocates had complained about unpredictable and inconsistent requests for additional information and other communications from the FDA causing US registration delays. Although this new chart is just a chart and not a track record of FDA review performance, it does provide a much clearer picture of what 510(k) applicants can expect from the US regulator once their registrations get underway.
Stewart Eisenhart covers medical device regulatory affairs for Emergo Group.